NASDAQ:RGC
Regencell Bioscience Holdings Limited
- Stock
Last Close
6.44
12/11 19:13
Market Cap
44.89M
Beta: -
Volume Today
12.21K
Avg: 926
PE Ratio
−17.51
PFCF: −20.60
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Jan '15 | Dec '15 | Dec '16 | Dec '17 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 157.70M - | 105.60M 33.04% | 153.40M 45.27% | 170.40M 11.08% | 112.30M 34.10% | -390.99K 100.35% | -812.37K 107.77% | -1.35M 65.78% | -7.59M 463.92% | -6.06M 20.18% | -4.30M 29.04% | |
depreciation and amortization | 204.50M - | 212M 3.67% | 216.80M 2.26% | 230.70M 6.41% | 254.80M 10.45% | 9.52K - | 26.46K 178.02% | 604.40K 2,184.54% | 769.69K 27.35% | 745.59K 3.13% | ||
deferred income tax | 11.80M - | -6.60M 155.93% | -10.90M 65.15% | 2.40M 122.02% | 600K 75% | 1.42K - | ||||||
stock based compensation | 9.30M - | 9.40M 1.08% | 8.30M 11.70% | 8.80M 6.02% | 9.20M 4.55% | 2.76M - | 922.62K 66.55% | |||||
change in working capital | -1.50M - | -42.90M 2,760% | 35.50M 182.75% | -67.40M 289.86% | -35M 48.07% | 76.28K - | 552.98K 624.91% | -1.02M 285.19% | -508.94K 50.30% | -585.37K 15.02% | ||
accounts receivables | -12M - | -4M 66.67% | -19M 375% | -7M 63.16% | -27M 285.71% | |||||||
inventory | -100K - | 1.30M 1,400% | -4.70M 461.54% | 1.50M 131.91% | -1.30M 186.67% | |||||||
accounts payables | 2M - | -200K 110.00% | 63.10M 31,650% | -38.30M 160.70% | 31.10M 181.20% | |||||||
other working capital | 8.60M - | -40M 565.12% | -3.90M 90.25% | -23.60M 505.13% | -37.80M 60.17% | 76.28K - | 552.98K 624.91% | -1.02M 285.19% | -508.94K 50.30% | -585.37K 15.02% | ||
other non cash items | -34.90M - | 71.60M 305.16% | 31.30M 56.28% | 65.60M 109.58% | 68M 3.66% | -10.73K - | -85.40K 695.68% | 139.93K 263.85% | ||||
net cash provided by operating activities | 346.90M - | 349.10M 0.63% | 434.40M 24.43% | 410.50M 5.50% | 409.90M 0.15% | -390.99K 100.10% | -726.57K 85.83% | -767.31K 5.61% | -5.27M 586.43% | -4.96M 5.77% | -4.00M 19.37% | |
investments in property plant and equipment | -112.10M - | -156.80M 39.88% | -185.70M 18.43% | -214.90M 15.72% | -250.40M 16.52% | -117.84K - | -780.88K - | -27.39K 96.49% | -5.37K 80.38% | |||
acquisitions net | -194.40M - | -171.60M - | 970.00 - | |||||||||
purchases of investments | -10M - | -10M 0% | -5M 50% | |||||||||
sales maturities of investments | 3.60M - | 10.09M - | 10.25M 1.61% | |||||||||
other investing activites | 157.30M - | 287.20M 82.58% | 2.40M 99.16% | -12.30M 612.50% | 11.40M 192.68% | |||||||
net cash used for investing activites | -149.20M - | 130.40M 187.40% | -183.30M 240.57% | -223.60M 21.99% | -410.60M 83.63% | -117.84K - | -10.78M - | 58.98K 100.55% | 5.24M 8,789.12% | |||
debt repayment | -13.50M - | -14.90M 10.37% | -986.50M 6,520.81% | -1.94B 96.28% | -3.40M 99.82% | |||||||
common stock issued | 40M - | 22.67M - | ||||||||||
common stock repurchased | -280.90M - | -147.10M 47.63% | -228.80M - | |||||||||
dividends paid | -132.20M - | -294.80M 123.00% | -139.10M 52.82% | -138.90M 0.14% | -138.90M 0% | |||||||
other financing activites | 469.80M - | 124.40M 73.52% | 947M 661.25% | 1.92B 102.24% | 354.10M 81.51% | 480.99K 99.86% | 988.08K 105.43% | 439.75K 55.50% | -267.97K 160.94% | 134.91K 150.35% | 102.28K 24.19% | |
net cash used provided by financing activities | 83.20M - | -332.40M 499.52% | -178.60M 46.27% | -160M 10.41% | -17M 89.38% | 480.99K 102.83% | 988.08K 105.43% | 439.75K 55.50% | 22.41M 4,995.12% | 134.91K 99.40% | 102.28K 24.19% | |
effect of forex changes on cash | -109M - | -280M 156.88% | -83.14K - | |||||||||
net change in cash | 171.90M - | -132.90M 177.31% | 72.50M 154.55% | 26.90M 62.90% | -17.70M 165.80% | 90.00K 100.51% | 143.67K 59.63% | -327.57K 328.00% | 6.36M 2,040.86% | -4.85M 176.32% | 1.40M 128.78% | |
cash at beginning of period | 109M - | 280M 156.88% | 147.10M 47.46% | 219.60M 49.29% | 246.50M 12.25% | 153.30K 99.94% | 243.31K 58.71% | 386.98K 59.05% | 59.41K 84.65% | 6.42M 10,700.66% | 1.56M 75.61% | |
cash at end of period | 280.90M - | 147.10M 47.63% | 219.60M 49.29% | 246.50M 12.25% | 228.80M 7.18% | 243.31K 99.89% | 386.98K 59.05% | 59.41K 84.65% | 6.42M 10,700.66% | 1.56M 75.61% | 2.96M 89.24% | |
operating cash flow | 346.90M - | 349.10M 0.63% | 434.40M 24.43% | 410.50M 5.50% | 409.90M 0.15% | -390.99K 100.10% | -726.57K 85.83% | -767.31K 5.61% | -5.27M 586.43% | -4.96M 5.77% | -4.00M 19.37% | |
capital expenditure | -112.10M - | -156.80M 39.88% | -185.70M 18.43% | -214.90M 15.72% | -250.40M 16.52% | -117.84K - | -780.88K - | -27.39K 96.49% | -5.37K 80.38% | |||
free cash flow | 234.80M - | 192.30M 18.10% | 248.70M 29.33% | 195.60M 21.35% | 159.50M 18.46% | -390.99K 100.25% | -844.41K 115.97% | -767.31K 9.13% | -6.05M 688.20% | -4.99M 17.49% | -4.01M 19.70% |
All numbers in USD (except ratios and percentages)